Although a preliminary bioinformatics study on the relationship between the CBX family and DLBCL has been published recently, there were still some shortcomings, such as too few clinical survival samples, in addition, some clinically relevant questions remain unanswered, such as the prognosis analysis based on multifactorial analysis. This evidence concerns the gene CBX1 and diffuse large B-cell lymphoma.